Hester Biosciences Ltd
NSE:HESTERBIO

Watchlist Manager
Hester Biosciences Ltd Logo
Hester Biosciences Ltd
NSE:HESTERBIO
Watchlist
Price: 2 403.9 INR 0.92% Market Closed
Market Cap: 20.4B INR
Have any thoughts about
Hester Biosciences Ltd?
Write Note

Hester Biosciences Ltd
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hester Biosciences Ltd
Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Hester Biosciences Ltd
NSE:HESTERBIO
Cash Equivalents
â‚ą167.9m
CAGR 3-Years
12%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
Cash Equivalents
â‚ą14.6m
CAGR 3-Years
11%
CAGR 5-Years
-40%
CAGR 10-Years
N/A
Transgene Biotek Ltd
BSE:526139
Cash Equivalents
â‚ą112k
CAGR 3-Years
6%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
Z
Zenotech Laboratories Ltd
BSE:532039
Cash Equivalents
â‚ą19m
CAGR 3-Years
-15%
CAGR 5-Years
-37%
CAGR 10-Years
-1%
Biocon Ltd
NSE:BIOCON
Cash Equivalents
â‚ą698m
CAGR 3-Years
-65%
CAGR 5-Years
-38%
CAGR 10-Years
-21%
Panacea Biotec Ltd
NSE:PANACEABIO
Cash Equivalents
â‚ą927.6m
CAGR 3-Years
N/A
CAGR 5-Years
1%
CAGR 10-Years
N/A
No Stocks Found

Hester Biosciences Ltd
Glance View

Market Cap
20.4B INR
Industry
Biotechnology

Hester Biosciences Ltd. is a holding company, which engages in the manufacture and trade of poultry vaccines and animal health products. The company is headquartered in Ahmedabad, Gujarat and currently employs 584 full-time employees. Its segments include Poultry division and Animal division. The company provides over 40 products across poultry vaccines (live and inactivated), animal vaccines (live and inactivated), health products and diagnostics. Its product range includes vaccines, drugs, feed supplements and disinfectants. The company manufactures over two live vaccines for large animals, including Peste des Petits Ruminants (PPR) Live vaccines and Goat Pox Vaccine. Its offerings include Avian, including Live B1, Live LAS, Live R2B, Live M48, Live FP, Gumboro M1, Gumboro I and Gumboro I+; swine fever vaccines, and animal, including PPR Vaccine-Sungri 96 strain and Brucella abortus (S19) calf Vaccine. The company offers services, such as seromonitoring for poultry farms and mastitis prevention programs for cattle farms.

HESTERBIO Intrinsic Value
1 593.33 INR
Overvaluation 34%
Intrinsic Value
Price

See Also

What is Hester Biosciences Ltd's Cash Equivalents?
Cash Equivalents
167.9m INR

Based on the financial report for Sep 30, 2024, Hester Biosciences Ltd's Cash Equivalents amounts to 167.9m INR.

What is Hester Biosciences Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
-17%

Over the last year, the Cash Equivalents growth was 29%. The average annual Cash Equivalents growth rates for Hester Biosciences Ltd have been 12% over the past three years , -17% over the past five years .

Back to Top